What Is APAP Codeine? Uses, Risks, and Side Effects

APAP codeine is a prescription pain reliever that combines two drugs: acetaminophen (abbreviated APAP, from its chemical name N-acetyl-para-aminophenol) and codeine phosphate, a mild opioid. The combination is often sold under the brand name Tylenol #3, though generic versions are widely prescribed. It works because the two ingredients attack pain through different pathways, producing stronger relief together than either drug alone. That synergy also means the medication carries risks from both sides of the equation, and understanding those risks matters more than most patients realize.

Why Two Drugs Are Combined in One Pill

Acetaminophen and codeine relieve pain through entirely different mechanisms, which is precisely why combining them makes pharmacological sense. The acetaminophen component was long thought to work mainly by blocking cyclooxygenase enzymes, similar to ibuprofen and aspirin. More recent research points to a different primary pathway: acetaminophen is converted in the body into a compound called AM404, which then acts on pain-modulating receptors in the brain, including cannabinoid receptors and a heat-sensing receptor called TRPV1.¹ That makes acetaminophen more of a centrally acting pain reliever than its reputation as a “mild” over-the-counter pill might suggest.

Codeine takes a separate route. On its own, codeine is actually a fairly weak drug. It needs to be converted by a liver enzyme called CYP2D6 into morphine before it becomes a potent painkiller.² Once that conversion happens, the morphine activates opioid receptors in the brain and spinal cord, dampening pain signals. Because acetaminophen and codeine hit separate targets, the combination produces what researchers describe as a synergistic analgesic effect that is comparable to nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.³

What APAP Codeine Is Typically Prescribed For

Doctors prescribe APAP codeine for mild to moderate pain that over-the-counter painkillers alone cannot handle. Common scenarios include pain after dental procedures, post-surgical discomfort from minor operations, musculoskeletal injuries, and sometimes short-term management of pain after childbirth. A study comparing ibuprofen to acetaminophen with codeine for perineal pain after delivery found that both provided similar relief in the first 24 hours, with nearly identical average pain scores and dosing frequency.⁴ The combination also sees use for cough suppression, since codeine has antitussive properties, though this application has become less common as concerns about opioid use have grown.

After outpatient breast surgery, a randomized trial found that patients given acetaminophen with codeine and caffeine (Tylenol #3) had similar pain outcomes compared to those receiving acetaminophen plus ibuprofen. Patient satisfaction was high in both groups. However, patients on the codeine combination were significantly more likely to stop taking the drug because of side effects: 19% discontinued it compared to just 6% in the ibuprofen group.⁵ That pattern shows up repeatedly in the literature: APAP codeine works, but patients often tolerate non-opioid alternatives better.

How It Stacks Up Against Ibuprofen for Dental Pain

Dental extractions, especially wisdom teeth, are one of the most studied pain models in pharmacology because the pain is predictable and short-lived. A systematic review and meta-analysis comparing acetaminophen-codeine to ibuprofen after third-molar extraction found that ibuprofen provided substantially greater total pain relief over six hours. The overall pain-relief scores for ibuprofen were roughly four times higher than those for the acetaminophen-codeine combination.⁶ That finding is worth knowing because many patients assume a prescription painkiller must be stronger than something you can buy at the pharmacy. For dental pain specifically, the evidence suggests otherwise.

This does not mean APAP codeine is useless for dental procedures. It still provides meaningful relief compared to placebo, and some patients cannot take NSAIDs due to stomach ulcers, kidney disease, or bleeding disorders. But if you have a choice and no contraindication to ibuprofen, the data favor ibuprofen for this particular type of pain.

Common Side Effects

The side effects of APAP codeine come almost entirely from the codeine half of the pill. Acetaminophen at normal doses is well tolerated by most people and produces few noticeable effects beyond pain relief. Codeine, on the other hand, is an opioid, and opioids bring a characteristic set of problems.

The most frequently reported side effects are drowsiness, dizziness, and nausea.⁷ In clinical trials comparing codeine-containing painkillers to stronger opioids like oxycodone, both groups reported drowsiness and dizziness, though the effects tended to be more pronounced with the stronger drug.⁸ This is relevant if your doctor offers a choice between APAP codeine and something stronger: the step up in pain relief may come with a steeper climb in side effects.

Constipation deserves special mention because it is not just an annoyance. Opioids activate receptors throughout the gut that slow down gastric emptying, block normal wave-like contractions, increase the tone of sphincter muscles, and reduce fluid secretion into the intestines.⁹ The result is hard, infrequent stools that can be genuinely uncomfortable. Unlike most opioid side effects, constipation does not improve much as your body adjusts. If you are taking APAP codeine for more than a day or two, staying hydrated and using a stool softener can help prevent what many patients describe as the worst part of the whole experience.

The comparison with ibuprofen comes up here too. In the postpartum pain trial mentioned earlier, significantly fewer patients in the ibuprofen group experienced side effects overall: about 52% reported at least one, versus roughly 72% in the acetaminophen-codeine group.⁴ That gap is substantial and helps explain why many prescribing guidelines now recommend trying non-opioid painkillers first.

Liver Damage from Acetaminophen

The serious risk on the acetaminophen side is liver toxicity. At standard doses, the liver processes acetaminophen safely. But when the dose is too high, or when the liver is already stressed by alcohol use or existing liver disease, the breakdown process generates a toxic byproduct called NAPQI. Normally the liver neutralizes NAPQI using a protective molecule called glutathione. When acetaminophen intake overwhelms the liver’s supply of glutathione, NAPQI accumulates, damages liver cells, and can trigger acute liver failure.¹⁰

Acetaminophen toxicity is actually the leading cause of acute liver failure in many Western countries, and a large share of those cases are accidental. The danger with APAP codeine is that patients sometimes forget the pill contains acetaminophen and take additional acetaminophen products on top of it: an extra-strength Tylenol for a headache, a cold medicine that also contains acetaminophen, or a nighttime sleep aid with acetaminophen buried in the ingredients list. The daily limit for acetaminophen in adults is generally considered to be 3,000 to 4,000 milligrams, with the lower number recommended for anyone who drinks alcohol regularly. If you are taking APAP codeine, check the label for the acetaminophen dose per tablet and count every milligram from every source.

Respiratory Depression from Codeine

The codeine half carries its own potentially fatal risk: respiratory depression. All opioids can slow breathing by acting on brain regions that regulate the rhythm and depth of each breath. Opioids bind to mu-opioid receptors located in breathing control centers, including the brain’s inspiratory rhythm generator.¹¹ Animal studies have shown that activating these receptors in the primary breathing pacemaker region can cut respiratory rate nearly in half.¹²

At prescribed doses in most adults, codeine’s respiratory effects are mild. In a large study of overdose cases, the rate of serious respiratory events requiring intubation or the opioid-reversal drug naloxone was low even among patients who had taken acetaminophen-codeine combinations in overdose. Only about 0.6% of those patients needed such interventions, and the difference compared to acetaminophen-only overdoses was not statistically significant.¹³ That said, adding other sedating substances changes the picture. The same study found that when a sedating antihistamine called doxylamine was combined with the acetaminophen-codeine product, the rate of serious respiratory events climbed to about 2%. Mixing APAP codeine with alcohol, benzodiazepines, muscle relaxants, or sedating antihistamines is where the respiratory risk becomes genuinely dangerous.

Why Codeine Affects People So Differently

One of the most important things about codeine is that it does not work the same way in everyone, and this is not just individual variation in the usual sense. It is genetic. Because codeine must be converted into morphine by the CYP2D6 enzyme to work, variations in the gene coding for that enzyme create dramatic differences in how people respond to the same pill.

Roughly 5 to 10 percent of people of European descent are “poor metabolizers,” meaning their CYP2D6 enzyme is sluggish or nonfunctional. For them, codeine barely works at all because very little of it gets converted into morphine.² If you have ever taken a codeine product and felt it did absolutely nothing for your pain, this may be why.

At the opposite extreme are “ultrarapid metabolizers,” people who carry extra copies of the CYP2D6 gene and convert codeine into morphine much faster and more completely than average. A case report in the New England Journal of Medicine described a patient with three or more functional copies of the gene who experienced codeine intoxication because the drug was converted to morphine at an abnormally high rate.¹⁴ For ultrarapid metabolizers, a standard dose of codeine can behave like a large dose of morphine, raising the risk of serious sedation and respiratory depression. The prevalence of ultrarapid metabolism varies by population, reaching as high as 29% in some East African and Middle Eastern populations while remaining under 2% in some East Asian groups.

Pharmacogenomic testing can identify your metabolizer status before you ever take the drug, but it is rarely done in routine clinical practice. If you have a strong family history of unusual opioid reactions, or if codeine has previously made you extremely drowsy or had no effect whatsoever, bringing this up with your prescriber is worthwhile.

The FDA Warning About Children

The genetic variability described above becomes especially dangerous in children. The FDA has issued a black box warning, the most serious type of safety alert on a drug label, specifically addressing the use of codeine in pediatric patients. The warning was driven by reports of codeine-related deaths in children who turned out to be ultrarapid metabolizers, particularly after tonsillectomy and adenoidectomy procedures performed for obstructive sleep apnea.¹⁵

Children recovering from airway surgery are already at heightened risk for breathing problems, and adding an opioid that might be converted to morphine at unpredictable rates proved to be a fatal combination in several cases. The FDA now contraindicates codeine use in children under 12 entirely and warns against its use in adolescents aged 12 to 18 who are obese or have conditions like obstructive sleep apnea that already compromise breathing. Many pediatric pain guidelines have moved away from codeine altogether, favoring acetaminophen or ibuprofen alone for mild to moderate pediatric pain and reserving other opioids with more predictable pharmacology for severe cases where opioids are genuinely needed.

Dependence and Misuse Potential

Codeine is a Schedule II, III, or V controlled substance depending on the formulation and country (in the United States, APAP codeine products are typically Schedule III). As an opioid, codeine can produce physical dependence with regular use, even at prescribed doses. Physical dependence means your body adapts to the drug’s presence, and stopping abruptly can trigger withdrawal symptoms: restlessness, muscle aches, insomnia, sweating, and gastrointestinal upset. This is distinct from addiction, which involves compulsive drug-seeking behavior, though the two can overlap.

The risk of developing problematic use is lower with codeine than with stronger opioids like oxycodone or hydrocodone, but it is not zero. One pattern that clinicians have documented is patients who begin taking APAP codeine for a legitimate pain condition and then continue requesting refills long after the original pain should have resolved, sometimes because they have developed tolerance and partly because mild opioid withdrawal feels like a return of pain. If you find yourself needing more of the medication to get the same relief, or dreading what will happen when you stop, those are signs to talk to your doctor rather than to increase the dose on your own.

How Different Countries Regulate Access

Regulation of codeine-containing products varies strikingly around the world, and the landscape has shifted in the past decade. In the United States, any product combining acetaminophen with codeine requires a prescription. In the United Kingdom, low-dose codeine products remain available over the counter from pharmacies, and the scale of that access is substantial: between 2013 and 2019, roughly 4.75 billion dosage units of codeine were sold over the counter in the UK, averaging about 72 dosage units per resident over that period.¹⁶

Australia took a different path. Until February 2018, Australians could buy low-dose codeine products without a prescription at pharmacies. The country’s drug regulator then rescheduled all codeine products to prescription-only, citing concerns about toxicity, dependence, and misuse.¹⁷ That move was controversial. Supporters argued it would reduce harm from chronic unsupervised use; critics worried it would push people toward more dangerous alternatives or overwhelm general practitioners with requests for prescriptions that pharmacists had previously managed.

The divergence between the UK and Australian approaches reflects a genuine policy tension. Over-the-counter access makes it easier for people with legitimate short-term pain to get relief without a doctor visit, but it also enables long-term unsupervised use that can slide into dependence without anyone noticing. Neither system has clearly won the argument, and the evidence on whether Australia’s rescheduling actually reduced codeine-related harm is still being evaluated.

Practical Tips If You Are Prescribed APAP Codeine

If your doctor prescribes this medication, a few practical points can help you use it more safely. First, read the label for the exact amount of acetaminophen per tablet and keep a running count of all acetaminophen you consume from every source throughout the day. Cold medicines, sleep aids, and even some prescription painkillers can contain hidden acetaminophen. Second, do not drink alcohol while taking APAP codeine. Alcohol stresses the liver in ways that make acetaminophen toxicity more likely, and it compounds the sedation from codeine. Third, expect constipation if you are taking the drug for more than a day or two, and plan for it with extra fluids and a stool softener rather than waiting until it becomes a problem.

If the medication does not seem to be helping with your pain, tell your prescriber rather than doubling up. You may be a poor CYP2D6 metabolizer, in which case codeine simply will not work well for you regardless of dose, and a different pain management strategy will serve you better. Conversely, if a standard dose makes you feel heavily sedated or extremely drowsy, that could signal ultrarapid metabolism, and your doctor should know about it. Finally, keep the medication secured and out of reach of children, given the particular risks codeine poses to younger patients.